OSLER

OSLER was a randomized trial comparing long-term evolocumab plus standard therapy vs. standard therapy alone. MAIN RESULTS:Efficacy and safety of evolocumab in reducing lipids and cardiovascular eventsN Engl J Med. 2015 Apr 16;372(16):1500-9. PRESENTATIONS OSLER Outcomes (Sabatine, ACC 2015)